ORIC — ORIC Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: ORIC Pharmaceuticals Q1 Net Income USD -25.011 Million
Oric Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Oric Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts In Phase 1b Trial Of ORIC-114 In Patients With Mutated NSCLC
Oric Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Oric Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Carvana Co, Oracle, Vail Resorts
Brief: Oric Pharmaceuticals Files For Mixed Shelf Size Not Disclosed
Brief: ORIC Pharmaceuticals Q4 Net Income USD -28.33 Million
U.S. RESEARCH ROUNDUP-Burlington Stores, Carrols Restaurant Group, Mastec
Brief: ORIC Pharma Provides Initial Phase 1B Data for ORIC-944
Brief: Oric Pharmaceuticals Inc Files For Shelf Of Up To 12.1 mln Shares Of Common Stock - SEC Filing
U.S. RESEARCH ROUNDUP-Adobe, Oracle, Visa
Brief: Initial Phase 1 Dose Escalation Data For Oric-533 In Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity And Strong Safety Profile Supporting Potential For Combination Development
Brief: ORIC Pharmaceuticals Q3 Net Income USD -25.478 Million
Oric Pharmaceuticals Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Oric Says Initial Phase 1 Dose Escalation Data Of Oric-114 In Patients With Egfr And Her2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile
U.S. RESEARCH ROUNDUP- Coeur Mining, FedEx, Uber Technologies
Oric Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: ORIC Pharmaceuticals Q2 income from operations USD -24.992 million